Symbiomix

Symbiomix Therapeutics is a biopharmaceutical company bringing innovative medicines to market for prevalent gynecological infections than can have serious health consequences. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world’s leading healthcare venture capital firms: OrbiMed, F-Prime Capital Partners, and HBM Partners. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.
ADVERTISEMENT

Viviendo con Cáncer de Seno Metastásico

Alrededor de 155,000 mujeres en los Estados Unidos viven con cáncer de seno metastásico.

Created With Support

Don’t Put Off Your Screening and Vaccination for Cervical Cancer

Screening and vaccination are vital for preventing cervical cancer, and women need to know the preventive tools available

Created With Support